[Bacillus anthracis: causative agent of anthrax]
- PMID: 11892436
[Bacillus anthracis: causative agent of anthrax]
Abstract
Anthrax, an acute infectious disease of historical importance, is once again regaining interest with its use as a biological weapon. It is caused by B. anthracis, a Gram positive spore forming rod usually surrounded by a capsule and producing toxin. It occurs most frequently as an epizootic or enzootic disease of herbivores that acquire spores form direct contact with contaminated soil. Spores can survive for many years in soil. Animal vaccination programs have reduced drastically the disease in developed countries. In humans, the disease is acquired following contact with anthrax infected animals or their products. 3 types of anthrax infection can occur: cutaneous, inhalational and gastro intestinal. Cutaneous anthrax is the most common observed form. When germination occurs, replicating bacteria release toxin leading to hemorrhage, edema, necrosis and death. Full virulence of B. anthracis requires the presence of both antiphagocytic capsule and 3 toxin components (protective antigen, lethal factor and edema factor). Most naturally occurring anthrax strains are sensitive to penicillin but resistant to third generation cephalosporins. Post exposure prophylaxis is indicated to prevent inhalational anthrax.
Similar articles
-
[Anthrax--continuous threat to humans and animals].Przegl Epidemiol. 2004;58(2):335-42. Przegl Epidemiol. 2004. PMID: 15517814 Review. Polish.
-
Anthrax--an overview.Med Sci Monit. 2003 Nov;9(11):RA276-83. Med Sci Monit. 2003. PMID: 14586293 Review.
-
[Anthrax].Ned Tijdschr Tandheelkd. 2003 May;110(5):198-9. Ned Tijdschr Tandheelkd. 2003. PMID: 12784517 Review. Dutch.
-
Quantitative pathology of inhalational anthrax I: quantitative microscopic findings.Mod Pathol. 2001 May;14(5):482-95. doi: 10.1038/modpathol.3880337. Mod Pathol. 2001. PMID: 11353060
-
[Anthrax--the Swedish perspective].Lakartidningen. 2001 Dec 12;98(50):5742-5. Lakartidningen. 2001. PMID: 11789095 Swedish.
Cited by
-
Determination of the glycation sites of Bacillus anthracis neoglycoconjugate vaccine by MALDI-TOF/TOF-CID-MS/MS and LC-ESI-QqTOF-tandem mass spectrometry.J Mass Spectrom. 2011 Oct;46(10):993-1003. doi: 10.1002/jms.1980. J Mass Spectrom. 2011. PMID: 22012665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical